17 Capital Partners’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-9,550
Closed -$353K 91
2022
Q1
$353K Buy
+9,550
New +$372K 0.37% 79
2021
Q3
Sell
-5,525
Closed -$506K 99
2021
Q2
$506K Buy
+5,525
New +$439K 0.47% 67

Other funds holding CDNA

17 Capital Partners's CDNA Position: Q2 2022 in Review

17 Capital Partners sold out of CareDx (CDNA) in Q2 2022, closing a stake of 9,550 shares — an estimated $353K sold.

17 Capital Partners first reported a position in CDNA in Q2 2021 and held it in 2 quarters. The position peaked at $506K in Q2 2021. 184 funds tracked by Wall St. Rank hold CDNA as of Q2 2022.

  • 17 Capital Partners reported no remaining CareDx position as of Q2 2022 after selling out during the quarter.
  • 17 Capital Partners sold 9,550 CareDx shares in Q2 2022, an estimated $353K.
  • 17 Capital Partners first reported a position in CareDx in Q2 2021 and held it in 2 quarters.
  • 17 Capital Partners's CareDx position peaked at $506K in Q2 2021.
  • 184 funds tracked by Wall St. Rank held CareDx as of Q2 2022.

Based on 17 Capital Partners's 13F filing for Q2 2022, filed 8 Jul 2022.